<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-F2M8RIAH</identifier><date>2022</date><creator>Marušič, Tjaša</creator><relation>documents/doc/F/URN_NBN_SI_doc-F2M8RIAH_001.pdf</relation><relation>documents/doc/F/URN_NBN_SI_doc-F2M8RIAH_001.txt</relation><format format_type="issue">1</format><format format_type="type">article</format><format format_type="extent">str. 40-44</format><identifier identifier_type="COBISSID_HOST">122913539</identifier><identifier identifier_type="ISSN">2820-5014</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-F2M8RIAH</identifier><language>eng</language><language>slv</language><publisher publisher_location="Ljubljana">Fakulteta za farmacijo, ŠSSFD</publisher><source>Placebo</source><rights>InC</rights><subject language_type_id="eng">gene therapy</subject><subject language_type_id="slv">gensko zdravljenje</subject><subject language_type_id="eng">immunotherapy</subject><subject language_type_id="slv">Imunoterapija</subject><subject language_type_id="slv">Sladkorna bolezen tip 2</subject><subject language_type_id="slv">sladkorna bolezen tipa 1</subject><subject language_type_id="eng">type 1 diabetes</subject><title>Gensko zdravljenje sladkorne bolezni tipa 1</title></Record>